SASH1 downregulation in different cancer types correlates with decreased patient survival and enhanced formation of metastasis, probably due to its pro-apoptotic activity and the capacity to block EMT (epithelial–mesenchymal transition). The gene discussed is SASH1; the disease is cancer.